Related Experiment Video
Updated: Jul 26, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
The decline of BCG immunity after neonatal vaccination: what about revaccination at one year?
H Aydinlioglu1, S Caglayan, S Kansoy
1SSK Tepecik Teaching Hospital, Izmir, Turkey.
Insights
BCG vaccine immunity wanes over time in newborns, dropping from 87% to 61% reactivity by 12 months. Revaccination ensures 100% reactivity, and scar presence indicates immunity.
Area of Science:
- Immunology
- Pediatrics
- Public Health
Background:
- The Bacillus Calmette-Guérin (BCG) vaccine is crucial for preventing tuberculosis (TB) in newborns.
- Understanding the duration and indicators of BCG vaccine-induced immunity is vital for public health strategies.
Purpose of the Study:
- To assess the persistence of tuberculin reactivity after BCG vaccination in healthy newborns.
- To evaluate the effectiveness of revaccination in nonreactive infants.
- To explore the correlation between BCG vaccination scar formation and tuberculin reactivity.
Main Methods:
- A cohort of 219 healthy newborns received the BCG vaccine.
- Tuberculin reactivity was measured at 3, 6, and 12 months post-vaccination.
- Scar assessment was performed on the left deltoid region.
Main Results:
- Tuberculin reactivity decreased from 87% at 3 months to 61% at 12 months.
- Revaccination of infants who were not reactive to tuberculin resulted in a 100% reactivity rate.
- A strong correlation was observed between tuberculin reactivity and the presence of a BCG vaccination scar.
Conclusions:
- BCG vaccine-induced immunity, as indicated by tuberculin reactivity, wanes significantly within the first year of life.
- Revaccination is effective in restoring tuberculin reactivity.
- BCG scar formation serves as a reliable indicator of a child's immunity to tuberculosis, potentially simplifying post-vaccination monitoring.
Abstract:
Two hundred and nineteen healthy newborns were vaccinated with the BCG vaccine, and their immunity was checked thereafter at 3, 6 and 12 months of age. We determined that 87% of tuberculin reactivity at 3 months declined to 61% at 12 months. Revaccination of nonreactive infants provided a 100% rate of reactivity. In the light of this information we propose a revision in the BCG vaccination programme in developing countries. We also found a close relationship between the tuberculin reactivity and scar formation after BCG vaccination, suggesting that a simple check of the left deltoid region for a BCG scar may give enough information about the child's immunity to tuberculosis.
Related Concept Videos
Vaccinations
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines
Smallpox

